Pulmonary function test interpretation
spirometry & lung volumes · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Structured interpretation of spirometry, lung volumes and gas transfer classifies disease as obstructive, restrictive or mixed and guides further work-up. Using reference equations with lower-limit-of-normal thresholds and z-scores avoids misclassification from fixed ratios.
Red flags
- Flattened inspiratory/expiratory loop suggesting upper-airway obstruction
- Rapidly falling FEV1 or FVC on serial testing
- Isolated low DLCO (consider pulmonary vascular disease)
- Severe reduction prompting urgent evaluation
Assessment
Differential diagnosis
- Obstructive disease (asthma, COPD, bronchiectasis)
- Restrictive disease (ILD, chest wall, neuromuscular)
- Mixed obstructive-restrictive disease
- Pulmonary vascular disease (isolated low DLCO)
- Normal variant / poor technique
Investigations
- Spirometry (FEV1, FVC, FEV1/FVC) pre and post bronchodilator
- Static lung volumes (TLC, RV) by plethysmography/gas dilution
- Diffusing capacity (DLCO, KCO)
- Flow-volume loop shape assessment
- Reference equations (e.g. GLI) with lower limit of normal / z-scores
Management
- Check test quality and reproducibility before interpreting
- Assess FEV1/FVC against the lower limit of normal to detect obstruction (not a fixed 0.70 alone)
- If obstructed, grade severity by FEV1 % predicted and assess bronchodilator response
- If FEV1/FVC is preserved but FVC is low, measure lung volumes to confirm restriction
- Confirm restriction with a reduced TLC
- Interpret DLCO: reduced in emphysema, ILD and pulmonary vascular disease; raised in asthma/haemorrhage
- Examine the flow-volume loop for upper-airway obstruction patterns
- Integrate with symptoms, imaging and history for a clinical diagnosis
- Use serial testing to track disease progression and treatment response
- Avoid over-reliance on a single ratio — interpret the whole pattern
Drugs & doses
Bronchodilator for reversibility testing: salbutamol 400 mcg via spacer, reassess at 15 min
No therapeutic drug; results guide disease-specific treatment
Withhold bronchodilators appropriately before reversibility testing
Disposition
Respiratory physiology/clinic; results direct disease-specific investigation and management.
Complications & pitfalls
- Misclassification from using a fixed FEV1/FVC ratio
- Missed restriction when only spirometry is performed
- Overdiagnosis of COPD in older patients using fixed ratios
- Poor-quality tests leading to wrong conclusions
Exam pearls
- Use the lower limit of normal / z-scores (GLI equations) rather than fixed cut-offs to avoid age-related misclassification
- Spirometry cannot diagnose restriction — you need lung volumes (TLC)
- A low KCO with low DLCO points to parenchymal/vascular disease; a preserved KCO suggests extrapulmonary restriction
- Always check test quality before interpreting numbers
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.